Cardiac Biomarkers Market Analysis | Investment Opportunities, Demand, Growth Analysis | Forecast to 2025

1
Cardiac Biomarkers Market
Global Industry Insight, Share, Size, Demand
Analysis, Trends Forecast to 2025
2
Cardiac Biomarkers Market
Cardiac Biomarkers Market Overview
Cardiac biomarkers are often referred to as
cardiac markers. The cardiac biomarkers
(endogens, including enzymes, hormones, and
proteins) are released into the blood if the
heart is damaged or stressed. Generally, they are
used to treat heart attack and acute coronary
syndrome (ACS) or disorders associated with
insufficient blood flow to the core According to
Market Research Future (MRFR), Cardiac Biomarkers
Market is expected to cross USD 4236.02 Million
2025 at a CAGR of 16.36 by 2025 (forecast
period). The research report serves as insight
and knowledge repository for all market aspects
including, regional markets, technology, types,
and applications.
3
Cardiac Biomarkers Market
Cardiac Biomarkers Market Segmentation The global
cardiac biomarkers market can be classified based
on type, location of testing, application, and
region. Based on type, the cardiac biomarkers
market can be segmented into Myocardial muscle
Creatine Kinase (CK-MB), troponins (T and I),
myoglobin, Brain Natriuretic Peptide (BNPs) or
NT-proBNP, ischemia-modified albumin (IMA), and
others. Owing to its prodigious sensitivity and
ability to reliably diagnose the heart events of
an acute coronary syndrome (ACS), Troponins I and
T are the leading revenue-generating segment in
the global cardiac biomarkers market. The
location of testing is further segmented into
point of care testing and laboratory testing. The
point of care testing is projected to see steady
growth in the forecast period due to its
increasing popularity. The laboratory testing
segment dominated the global market for cardiac
biomarkers. Increased demand for cardiovascular
disease diagnostics is increasing the revenue of
this segment. In terms of application, the demand
for cardiac biomarkers can be divided in terms of
diagnosis into congestive heart failure,
myocardial infarction, acute coronary syndrome,
atherosclerosis, and others. Get Free Sample
of Report _at_ https//www.marketresearchfuture.com/s
ample_request/8594
4
Cardiac Biomarkers Market
Cardiac Biomarkers Market Regional Analysis
Regionally, the cardiac biomarkers market can be
classified into five regional markets, such as
North America, Europe, Asia Pacific, Latin
America, and Middle East Africa. North America
and Europe dominate the global market for cardiac
biomarkers due to an increasing population of
patients suffering from cardiovascular disease
(angina pectoris, myocardial infringement, etc.),
lack of physical activity, and poor diet. Europe
has one of the best healthcare services in the
world, and the increasing participation of market
players is boosting the European market for
cardiac biomarkers. For example, in October 2019,
Novartis received FDA approval for Entresto for
the treatment of symptomatic heart failure in
pediatric patients aged one year and older. The
Middle East and Africa have mainly been divided
into two regions The Middle East and Africa. The
presence of favourable government initiatives and
recent health reforms and the development of
healthcare infrastructure in the Middle East is
expected to increase market growth over the
forecast period. Moreover, India, Southeast Asia,
and China are evolving markets for cardiac
biomarkers due to an increased incidence of
coronary artery disease in these regions.
Initiatives by the Government of Asia-Pacific
towards the development of health care
infrastructure are also expected to boost the
growth of the market for cardiac biomarkers in
the region.
Browse Report _at_ https//www.marketresearchfuture.c
om/reports/cardiac-biomarkers-market-8594
5
Cardiac Biomarkers Market
Cardiac Biomarkers Market Competitive Analysis
Key companies operating in the global cardiac
biomarkers market are Abbott Laboratories, ACS
Biomarker (The Netherlands), BD (Becton,
Dickinson, and Company) (US), bioMérieux SA
(France), Bio-Rad Laboratories, Inc. (US),
Danaher Corporation (US), Hoffmann-La Roche Ltd
(Switzerland), Johnson and Johnson (US), Quidel
Corporation (US), Randox Laboratories Limited
(UK), Siemens AG (Germany), Thermo Fisher
Scientific, Inc. (the US), and others.
Ask Questions To The Experts _at_ https//www.marketr
esearchfuture.com/enquiry/8594
6
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
7
(No Transcript)